HLYKD / HealthLynked Corp. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 HealthLynked Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Num

Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform

Exhibit 99.1 Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) - via IBN - HealthLynked Corp. (OTCQB: HLYK) - Dear Shareholders, I’m writing to share an important update in the continued evolution of HealthLynked Corp. that reflects our commitment to long-term growth and enhanced shareholder

! " # $% % & & '( ) " #

Exhibit 3.1 ! " # $% % & & '( ) " # Profit Corporation: Certificate of Amendment (PURSUANT TO NRS 78 380 & 78.385/78.390) Certificate to Accompany Restated Articles or Amended and Restated Articles ‹ URSUANT TO NRS 78.403) Officer's Statement (PURSUANT TO NRS 80 030) Date: 09/04/2025 Time: 12:01AM EST (must not be later than 90 days after the certificate is filed) 4. Effective Date and Time: (Opti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

7915 FM 1960 W Suite 220 Houston, TX 77070 www.rbsmllp.com Exhibit 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the inclusion in this Offering Statement on Form 1-A, of our report dated March 31, 2025, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements

Total Output Management Agreement AP9UCATlOHNO. AGREEMENT NO. Tim words'ttesr." •saaee. ƒ u" and Y' rafer to custa«ter. The words her. - ƒ twssor," W,”“us• and •our refbr to Zsne offIce.8oluttona, Inc. Naples FL BBJ.INONAME {IP DIFFERENT FROM ABOUE}

Exhibit 6.6 Date: January 19th, 2022 SALES ORDER Sales Rep: Jason Kohlmeier PO Numbei SHIP TO BiLL TO HealthLynked Corp. Company: Company: HealthLynked Corp. 1265 Creekside Parkway, Suite #302 Address: 1265 Creekside Parkway, Suite #302 Address: Naples State: FL Zip: 34108 City: Naples state: FL Zip: 34108 city: Thomas Nguyen Contact: Thomas Nguyen Contact: 800 - 928 - 7144 Fax: Phone: 800 - 928 7

COMMON STOCK PURCHASE WARRANT

Exhibit 3.12 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST

COMMON STOCK PURCHASE WARRANT

Exhibit 3.6 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

LOAN AUTHORIZATION AND AGREEMENT (LA&A) A PROPERLY SIGNED DOCUMENT IS REQUIRED PRIOR TO ANY

Exhibit 3.20 SBA Loan #6706688201 Application #3306498487 LOAN AUTHORIZATION AND AGREEMENT (LA&A) A PROPERLY SIGNED DOCUMENT IS REQUIRED PRIOR TO ANY DISBURSEMENT CAREFULLY READ THE LA&A: This document describes the terms and conditions of your loan. It is your responsibility to comply with ALL the terms and conditions of your loan. SIGNING THE LA&A: All borrowers must sign the LA&A. ● Sign your n

NONRESIDENTIAL LEASE

Exhibit 6.3 NONRESIDENTIAL LEASE THIS NONRESIDENTIAL LEASE (this “Lease”) is between Muriel Court. L.P., a Delaware limited partnership, c/o AJS Realty Group, Inc., of 4980 Tamiami Trail N, Suite 201, Naples, FL 34103 (“Landlord”), and Bridging The Gap Physical Therapy, a Florida limited liability company (“Tenant”), whose address for the purpose of notice is 28410 Bonita Crossings Boulevard, Suit

LOAN AUTHORIZATION AND AGREEMENT (LA&A) A PROPERLY SIGNED DOCUMENT IS REQUIRED PRIOR TO ANY

Exhibit 3.18 LOAN AUTHORIZATION AND AGREEMENT (LA&A) A PROPERLY SIGNED DOCUMENT IS REQUIRED PRIOR TO ANY DISBURSEMENT CAREFULLY READ THE LA&A: This document describes the terms and conditions of your loan. It is your responsibility to comply with ALL the terms and conditions of your loan. SIGNING THE LA&A: All borrowers must sign the LA&A. ● Sign your name exactly as it appears on the LA&A. If typ

LOAN AUTHORIZATION AND AGREEMENT (LA&A) A PROPERLY SIGNED DOCUMENT IS REQUIRED PRIOR TO ANY DISBURSEMENT

Exhibit 3.19 LOAN AUTHORIZATION AND AGREEMENT (LA&A) A PROPERLY SIGNED DOCUMENT IS REQUIRED PRIOR TO ANY DISBURSEMENT CAREFULLY READ THE LA&A: This document describes the terms and conditions of your loan. It is your responsibility to comply with ALL the terms and conditions of your loan. SIGNING THE LA&A: All borrowers must sign the LA&A. ● Sign your name exactly as it appears on the LA&A. If typ

COMMON STOCK PURCHASE WARRANT

Exhibit 3.7 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

COMMON STOCK PURCHASE WARRANT

Exhibit 3.16 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST

COMMON STOCK PURCHASE WARRANT

Exhibit 3.13 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST

HEALTHLYNKED CORP. COMMON STOCK PURCHASE WARRANT

Exhibit 3.17 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO

COMMERCIAL LEASE

Exhibit 6.4 COMMERCIAL LEASE 1.01 This lease (Lease) is made June 4 2020, between RES FLORJDA 1265 HOLDINGS, LLC, a Florida limited liability company (“Landlord”), and Naples Women’s Center (“Tenant”). 1.02 Premises. Landlord leases to Tenant the real property described in the attached Exhibit “A” (the “Premises”), which are contemplated to be located on the second floor of the building. in which

PRELIMINARY OFFERING CIRCULAR - DATED APRIL 30, 2025 SUBJECT TO COMPLETION HEALTHLYNKED CORP. Registrant’s principal address: 1265 Creekside Parkway, Suite 302, Naples FL 34108 Registrant’s telephone number, including area code: (800) 928-7144 Regist

AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.

COMMERCIAL LEASE

Exhibit 6.5 COMMERCIAL LEASE 1.01 This lease (Lease) is made 1 day of October 2020, between RES FLORIDA 1265 HOLDINGS, LLC, a Florida limited liability company (“Landlord”), and HealthLynked Corporation, a Florida Corporation (“Tenant”) 1.02 Premises. Landlord leases to Tenant the real property described in the attached Exhibit “A” (the “Premises”), which are contemplated to be located on the thir

DEALMAKER ORDER FORM Regulation A Offerings (each, an “Offering”)

Exhibit 6.1 DEALMAKER ORDER FORM Regulation A Offerings (each, an “Offering”) Customer:. HealthLynked Contact: Dr. Michael Dent Address: 1265 Creekside Pkwy Suite 301 Naples, Fl 34108 Phone: Commencement Date (optional): E-Mail: [email protected] This Order Form sets forth the terms of service by which a number of separate DealMaker affiliates are engaged to provide services to Customer (coll

WARRANT AGREEMENT HEALTHLYNKED CORPORATION

Exhibit 3.3 THE SECURITIES REPRESENTED HEREBY, INCLUDING THE SHARES ISSUABLE UPON EXERCISE HEREOF, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRE D, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH AC

NOTE EXTENSION AGREEMENT

Exhibit 3.15 NOTE EXTENSION AGREEMENT This Extension Agreement (the “Agreement”) is entered into as of June 27, 2024 by and between the Mary S. Dent Gifting Trust (the “Holder”) and HealthLynked Corp., a Nevada corporation (the “Company”). RECITALS WHEREAS, on March 27, 2024, the Company issued to Holder an unsecured promissory note (the “Note”) with a face value of $350,000 and a Maturity Date (a

EMPLOYMENT AGREEMENT

Exhibit 6.7 Execution Copy EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement) is made this 1st day of July, 2016 between HealthLynked, Corp .. a Nevada corporation (“HealthLynked” or the “Employer” and collectively with any entity that is wholly or partially owned by HealthLynked, the “Company”), located at 1726 Medical Blvd Suite 101 Naples, Florida 334110 and Michael T. Dent M.D. (“Exec

Page 1 of 4

Exhibit 6.9 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the “Agreement”) is made and entered into the day of date, January 15, 2025 by and between HealthLynked Corp (the “Company”) and Jeremy D. Daniel (the “Consultant”). 1. Engagement. The Company hereby engages the Consultant to provide, and the Consultant hereby agrees to provide the consulting services with respect to key business initiati

SUITES 160 & 270 COMMONS V MEDICAL OFFICE BUILDING NAPLES, FLORIDA Building Reference No.: 110501 MEDICAL OFFICE BUILDING LEASE HTA- COMMONS V, LLC, a Delaware limited liability company HLYK FLORIDA, LLC, a Florida limited liability company

Exhibit 6.2 EXECUTION COPY SUITES 160 & 270 COMMONS V MEDICAL OFFICE BUILDING NAPLES, FLORIDA Building Reference No.: 110501 MEDICAL OFFICE BUILDING LEASE BETWEEN HTA- COMMONS V, LLC, a Delaware limited liability company (“LANDLORD”) AND HLYK FLORIDA, LLC, a Florida limited liability company (“TENANT”) Commons V MOB Naples, FL HRG (HTA BUILDING NO. 110501) HLYK Florida, LLC - Lease TABLE OF CONTEN

COMMON STOCK PURCHASE WARRANT

Exhibit 3.9 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

SUBSCRIPTION AGREEMENT

Exhibit 4.1 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES OR BLUE SKY LAWS AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHAN

COMMON STOCK PURCHASE WARRANT

Exhibit 3.8 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

COMMON STOCK PURCHASE WARRANT

Exhibit 3.10 NEITHER THIS SECURITY NOR THE SECURITIES FOR WH ICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIS

WARRANT AGREEMENT

Exhibit 3.2 THE SECURITIES REPRESENTED HERE BY, INCLUDING THE SHARES ISSUABLE UPON EXERCISE HERE OF, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST THERE IN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH

Healthlynked Corp.

Exhibit 12.1 Healthlynked Corp. 1265 Creekside Parkway, Suite 302 Naples FL 34108 April 30, 2025 Re: Form 1-A Offering Statement Ladies and Gentlemen: Dodson Robinette, PLLC dba Crowdfunding Lawyers has acted as counsel to Healthlynked Corp., a Nevada corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission of a Regulation A Offering St

COMMON STOCK PURCHASE WARRANT

Exhibit 3.4 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFF

COMMON STOCK PURCHASE WARRANT

Exhibit 3.11 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UND ER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST

HEALTHLYNKED CORP. COMMON STOCK PURCHASE WARRANT

Exhibit 3.14 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO

COMMON STOCK PURCHASE WARRANT

Exhibit 3.5 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

Insider Trading Policy

Exhibit 19.1 HEALTHLYNKED CORP. INSIDER TRADING COMPLIANCE PROGRAM Updated: December 15, 2021 In order to take an active role in the prevention of insider trading violations by its officers, directors, employees and other related individuals of HealthLynked Corp. (the “Company”) and its subsidiaries, the Company has adopted the policies and procedures described in this Memorandum. I. Adoption of I

Subsidiaries

EXHIBIT 21.1 Subsidiaries 1. Naples Women’s Center, LLC 2. HLYK Florida, LLC, dba Naples Center for Functional Medicine 3. ACO Health Partners LLC 4. Bridging the Gap Physical Therapy LLC 5. MEDOFFICEDIRECT L.L.C. dba MedOffice Direct 6. Naples Advanced Women’s Care, LLC 7. Aesthetic Enhancements Unlimited, LLC 8. Concierge Care Naples LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55768 HealthLynked Corp. (Exact

Notes Extension Agreement dated March 20, 2025

Exhibit 10.2 NOTES EXTENSION AGREEMENT This Notes Extension Agreement (the “Agreement”) is entered into as of March 20, 2025 by and between the Mary S. Dent Gifting Trust (the “Holder”) and HealthLynked Corp., a Nevada corporation (the “Company”). RECITALS WHEREAS, during 2024, the Company issued to Holder the following unsecured promissory notes (collectively, the “Notes”): Note Scheduled Note Ty

Common Stock Purchase Warrant dated March 20, 2025

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

Convertible Promissory Note dated March 20, 2025

Exhibit 10.1 THESE SECURITIES HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF FEDERAL AND STATE SECURITIES LAWS OR EXEMPT FROM SUCH REGISTRATION AND QUALIFICATION REQUIREMENTS. HEALTHLYNKED CORP. CONVERTIBLE PROMISSORY NOTE Ori

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2025 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement HEALTHLYNKED CORP. (Name of Registrant as Specif

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement HEALTHLYNKED CORP. (Name of Registrant as Specif

2024 SHAREHOLDER LETTER 00 Table of Contents CEO Perspective 01 02 03 06 09 Company Focus Product Development Larger Mission Looking into the Future Contact Information 11 01 CEO Perspective Michael Dent M.D. CEO “ 2024 marked a pivotal year for Heal

Exhibit 99.1 2024 SHAREHOLDER LETTER 00 Table of Contents CEO Perspective 01 02 03 06 09 Company Focus Product Development Larger Mission Looking into the Future Contact Information 11 01 CEO Perspective Michael Dent M.D. CEO “ 2024 marked a pivotal year for HealthLynked, underlining our commitment to revolutionizing healthcare connectivity and accessibility. We broadened the reach of our telemedi

HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future “Highlights 2024 Collaborative Partnerships and Product Development Designed to Spur Growth in 2025 and Beyond”

Exhibit 99.2 HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future “Highlights 2024 Collaborative Partnerships and Product Development Designed to Spur Growth in 2025 and Beyond” Naples, Florida – February 4, 2025 – HealthLynked Corp. (OTCQB: HLYK), a leading innovator in healthcare technology focused on revolutionizing pa

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2025 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Numb

HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer

Exhibit 99.1 HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer NAPLES, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) - HealthLynked Corp. (OTCQB: HLYK), a pioneering provider of healthcare technology solutions, is proud to announce the appointment of Jeremy Daniel as its new Chief Financial Officer (CFO), effective immediately. With an impressive career spanning over two decades, Mr. Daniel br

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2025 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLy

Common Stock Purchase Warrant dated September 19, 2024

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO A

Senior Secured Convertible Promissory Note 6 dated September 19, 2024

Exhibit 10.8 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING T

Notes and Warrant Purchase Agreement, by and among the Company and the Purchaser, dated June 3, 2024

Exhibit 10.1 HealthLynked Corp. NOTES AND WARRANT PURCHASE AGREEMENT THIS NOTES AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is made as of September 19, 2024 by and between HEALTHLYNKED CORP., a Nevada corporation (the “Company”), and the Mary S. Dent Gifting Trust (the “Investor”). THE PARTIES HEREBY AGREE AS FOLLOWS: 1. Purchase and Sale of Convertible Notes and Warrant. 1.1 Sale and Issuan

Senior Secured Convertible Promissory Note 5 dated September 19, 2024

Exhibit 10.7 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING T

Senior Secured Convertible Promissory Note 4 dated September 19, 2024

Exhibit 10.6 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING T

Senior Secured Convertible Promissory Note 2 dated September 19, 2024

Exhibit 10.4 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING T

Senior Secured Convertible Promissory Note 1 dated September 19, 2024

Exhibit 10.3 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING T

Senior Secured Convertible Promissory Note 9 dated September 19, 2024

Exhibit 10.11 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING

Senior Secured Convertible Promissory Note 7 dated September 19, 2024

Exhibit 10.9 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING T

Security Agreement, by and among the Company and the Mary S. Dent Gifting Trust, dated September 19, 2024 (Filed as Exhibit 10.2 to the Company’s Form 8-K filed with the Commission on September 24, 2024)

Exhibit 10.2 SECURITY AGREEMENT THIS SECURITY AGREEMENT (as amended, restated, supplemented, extended or otherwise modified from time to time, this “Agreement”) dated as of September 19, 2024, is entered into by and among HealthLynked Corp., a Nevada corporation, as debtor (“Debtor”), in favor of the Mary S. Dent Gifting Trust, for the benefit of itself as collateral agent (together with any succe

Senior Secured Convertible Promissory Note 3 dated September 19, 2024

Exhibit 10.5 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING T

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2024 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Nu

Senior Secured Convertible Promissory Note 8 dated September 19, 2024

Exhibit 10.10 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING

Senior Secured Convertible Promissory Note 10 dated September 19, 2024

Exhibit 10.12 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

HealthLynked Promotes Bill Crupi to Chief Operating Officer

Exhibit 99.1 HealthLynked Promotes Bill Crupi to Chief Operating Officer NAPLES, Fla., June 26, 2024 — HealthLynked Corp. (OTCQB: HLYK), a pioneering provider of healthcare technology solutions, is pleased to announce the promotion of Bill Crupi to the position of Chief Operating Officer (COO), effective immediately. This strategic appointment underscores HealthLynked’s commitment to operational e

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2024 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Number)

Note and Warrant Purchase Agreement, by and among the Company and the Purchaser, dated June 3, 2024

Exhibit 10.1 HealthLynked Corp. NOTE AND WARRANT PURCHASE AGREEMENT THIS NOTE AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is made as of June 3, 2024 by and between HEALTHLYNKED CORP., a Nevada corporation (the “Company”), and the Mary S. Dent Gifting Trust (the “Investor”). THE PARTIES HEREBY AGREE AS FOLLOWS: 1. Purchase and Sale of Convertible Note and Warrant. 1.1 Sale and Issuance of Con

Senior Secured Convertible Promissory Note dated June 3, 2024

Exhibit 10.2 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR SUCH LAWS COVERING T

Common Stock Purchase Warrant dated June 3, 2024

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO A

Dr. Michael Dent Finances $1 Million to Drive HealthLynked’s Healthcare Transformation

Exhibit 99.1 Dr. Michael Dent Finances $1 Million to Drive HealthLynked’s Healthcare Transformation Naples, FL – June 5, 2024 – HealthLynked Corp (OTCQB: HLYK), a leader in personalized healthcare and patient-centric services, proudly announces a $1 million financing by its CEO, Dr. Michael Dent. This financing underscores Dr. Dent’s unwavering belief in the company’s mission and his commitment to

Security Agreement, by and among the Company and the Mary S. Dent Gifting Trust, dated June 3, 2024 (Filed as Exhibit 10.3 to the Company’s Form 8-K filed with the Commission on June 5, 2024)

Exhibit 10.3 SECURITY AGREEMENT THIS SECURITY AGREEMENT (as amended, restated, supplemented, extended or otherwise modified from time to time, this “Agreement”) dated as of June 3, 2024, is entered into by and among HealthLynked Corp., a Nevada corporation, as debtor (“Debtor”), in favor of the Mary S. Dent Gifting Trust, for the benefit of itself as collateral agent (together with any successor a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 HealthLynked Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55768 HealthLynked Corp. (Exact

EX-21.1

Exhibit 21.1 Subsidiaries 1. Naples Women’s Center, LLC 2. HLYK Florida, LLC, dba Naples Center for Functional Medicine and dba Cura Health Management 3. ACO Health Partners LLC 4. Bridging the Gap Physical Therapy LLC 5. MEDOFFICEDIRECT L.L.C. dba MedOffice Direct 6. Naples Advanced Women’s Care, LLC 7. Aesthetic Enhancements Unlimited, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2024 HealthLynked Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2024 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2024 HealthLynked Corp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2024 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Numbe

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2023 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Num

Shareholder Letter

Exhibit 99.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLy

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55768 HealthLynked Corp. (Exact

EX-21.1

EXHIBIT 21.1 Subsidiaries 1. Naples Women’s Center, LLC 2. HLYK Florida, LLC, dba Naples Center for Functional Medicine and dba Cura Health Management 3. ACO Health Partners LLC 4. Bridging the Gap Physical Therapy LLC 5. MEDOFFICEDIRECT L.L.C. dba MedOffice Direct 6. Naples Advanced Women’s Care, LLC 7. Aesthetic Enhancements Unlimited, LLC

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2023 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2023 HealthLynked Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2023 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Number

HealthLynked Announces Appointment of Paul J. Hobaica, MD to its Board of Directors

Exhibit 99.1 HealthLynked Announces Appointment of Paul J. Hobaica, MD to its Board of Directors Naples, FL, March 14, 2023 - HealthLynked (OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connect doctors, patients, and medical data, is pleased to announce the appointment of Paul J. Hobaica, MD to its Board of Direct

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2023 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Numb

Agreement and Plan of Merger, dated January 17, 2023, among ACO Health Partners, LLC, HealthLynked Corp., PBACO Holding, LLC and AHP Acquisition, LLC (Filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Commission on January 23, 2023)

Exhibit 10.1 AGREEMENT AND PLAN OF MERGER BY AND AMONG PBACO HOLDING, LLC, ACO HEALTH PARTNERS, LLC, THE SELLER EQUITY OWNERS IDENTIFIED HEREIN, AND AHP ACQUISITION, LLC January 17, 2023 Table of Contents Page ARTICLE 1. Defined Terms 2 1.1 Defined Terms 2 ARTICLE 2. The Merger 2 2.1 The Merger 2 2.2 Closing 2 2.3 Effective Time 2 2.4 Effects of the Merger 2 2.5 Articles of Organization; Operating

Management Services Agreement, dated January 17, 2023 (Filed as Exhibit 10.2 to the Company’s Form 8-K filed with the Commission on January 23, 2023)

EX-10.2 3 ea171927ex10-2health.htm MANAGEMENT SERVICES AGREEMENT, DATED JANUARY 17, 2023 Exhibit 10.2 MANAGEMENT SERVICES AGREEMENT This Management Services Agreement (the “Agreement”) is effective as of this 17th day of January, 2023 (“Effective Date”) by and between PBACO HOLDING, LLC, a Florida limited liability company (the “Manager”), and ACO HEALTH PARTNERS, LLC, a Delaware limited liability

HealthLynked Announces Sale of ACO Health Partners Consideration Up to $3 Million in Cash and $7 Million in IPO Shares of PBACO

Exhibit 99.1 HealthLynked Announces Sale of ACO Health Partners Consideration Up to $3 Million in Cash and $7 Million in IPO Shares of PBACO Naples, Fla., January 20, 2023 — HealthLynked (OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connect doctors, patients, and medical data, today announced that it has signed a

Amended and Restated Promissory Note, dated November 15, 2022

EX-10.1 2 ea168989ex10-1healthlynked.htm AMENDED AND RESTATED PROMISSORY NOTE, DATED NOVEMBER 15, 2022 Exhibit 10.1 THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THIS NOTE HAS BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2022 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Num

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLy

Non-Disclosure, Non-Solicitation and Non-Compete Agreement between HealthLynked Corp. and George O’Leary, dated October 13, 2022 (Filed as Exhibit 10.2 to the Company’s Form 8-K filed with the Commission on October 19, 2022)

EX-10.2 3 ea167311ex10-2health.htm NON-DISCLOSURE, NON-SOLICITATION AND NON-COMPETE AGREEMENT BETWEEN HEALTHLYNKED CORP. AND GEORGE O'LEARY, DATED OCTOBER 13, 2022 Exhibit 10.2 HEALTHLYNKED CORP. NON-DISCLOSURE, NON-SOLICITATION AND NON-COMPETE AGREEMENT THIS NONDISCLOSURE, NON-SOLICITATION AND NON-COMPETE AGREEMENT (the “Agreement”) is made and entered into to be effective as of September 20, 202

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2022 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Numb

Extension Letter Agreement, by and between HealthLynked Corp. and George O’Leary, dated October 13, 2022 (Filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Commission on October 19, 2022)

EX-10.1 2 ea167311ex10-1health.htm EXTENSION LETTER AGREEMENT, BY AND BETWEEN HEALTHLYNKED CORP. AND GEORGE O'LEARY, DATED OCTOBER 13, 2022 Exhibit 10.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

Promissory Note, dated July 19, 2022

EX-10.1 2 ea163190ex10-1healthly.htm PROMISSORY NOTE, DATED JULY 19, 2022 Exhibit 10.1 THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THIS NOTE HAS BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2022 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Number)

HEALTHLYNKED CORP. 1265 Creekside Parkway, Suite 302 Naples, Florida 34108

CORRESP 1 filename1.htm HEALTHLYNKED CORP. 1265 Creekside Parkway, Suite 302 Naples, Florida 34108 July 15, 2022 VIA EDGAR United States Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: HealthLynked Corp. Request for Acceleration of Registration Statement on Form S-1 File No. 333-266088 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as a

List of Subsidiaries

Exhibit 21.1 Subsidiaries 1. Naples Women?s Center, LLC 2. HLYK Florida, LLC, dba Naples Center for Functional Medicine and dba Cura Health Management 3. ACO Health Partners LLC 4. Bridging the Gap Physical Therapy LLC 5. MEDOFFICEDIRECT L.L.C. dba MedOffice Direct 6. Aesthetic Enhancements Unlimited, LLC, d.b.a. Aesthetic Treatment Centers

As filed with the U.S. Securities and Exchange Commission on July 11, 2022

As filed with the U.S. Securities and Exchange Commission on July 11, 2022 Registration No. 333-[] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HealthLynked Corp. (Exact Name of Registrant as specified in its charter) Nevada 7373 47-1634127 (State or other Jurisdiction of Incorporation or Organization) (Pri

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) HealthLynked Corp.

Note Purchase Agreement, dated July 5, 2022, by and between HealthLynked Corp. and YA II PN, Ltd.

Exhibit 10.2 NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT (this ?Agreement?) is dated as of July 5, 2022, by and between HEALTHLYNKED CORP., a corporation organized and existing under the laws of the State of Nevada (the ?Company?), and YAII PN, LTD., a Cayman Islands exempt limited partnership (the ?Investor?). WITNESSETH WHEREAS, the parties desire that, upon the terms and subject to the

Standby Equity Purchase Agreement, dated July 5, 2022, by and between HealthLynked Corp. and YA II PN, Ltd. (Filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on July 8, 2022)

EX-10.1 2 ea162603ex10-1healthly.htm STANDBY EQUITY PURCHASE AGREEMENT, DATED JULY 5, 2022, BY AND BETWEEN HEALTHLYNKED CORP. AND YA II PN, LTD Exhibit 10.1 STANDBY EQUITY PURCHASE AGREEMENT THIS STANDBY EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of July 5, 2022 is made by and between YA II PN, LTD., a Cayman Islands exempt limited partnership (the “Investor”), and HEALTHLYNKED CORP., a

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 5, 2022 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55768 Healt

HEALTHLYNKED CORP. 1265 Creekside Parkway, Suite 302 Naples, Florida 34108 Tel: (800) 928-7144

HEALTHLYNKED CORP. 1265 Creekside Parkway, Suite 302 Naples, Florida 34108 Tel: (800) 928-7144 June 1, 2022 By EDGAR Transmission Frank Wyman Division of Corporation Finance Office of Life Sciences U.S. Securities and Exchange Commission Re: HealthLynked Corp Form 10-K for the Fiscal Year Ended December 31, 2021 Filed March 31, 2022 File No. 000-55768 Dear Mr. Wyman, We hereby submit the responses

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2022 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Number)

HealthLynked Announces Acquisition of Aesthetic Enhancements, LLC, and Reports First Quarter 2022 Results Including a Significant Reduction in Net Loss Company grows its Health Services Division with profitable cosmetic practice acquisition

Exhibit 99.1 HealthLynked Announces Acquisition of Aesthetic Enhancements, LLC, and Reports First Quarter 2022 Results Including a Significant Reduction in Net Loss Company grows its Health Services Division with profitable cosmetic practice acquisition Naples, Fla., May 17, 2022 ? HealthLynked Corp. (OTCQB: HLYK), (?HealthLynked? or the ?Company?), a global healthcare network focused on care mana

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

EX-21.1

EX-21.1 3 f10k2021ex21-1healthlynked.htm SUBSIDIARIES EXHIBIT 21.1 Subsidiaries 1. Naples Women’s Center, LLC 2. HLYK Florida, LLC, dba Naples Center for Functional Medicine and dba Cura Health Management 3. ACO Health Partners LLC 4. Bridging the Gap Physical Therapy LLC 5. MEDOFFICEDIRECT L.L.C. dba MedOffice Direct 6. Naples Advanced Women’s Care, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55768 HealthLynked Corp. (Exact

Description of our Common Stock (Filed as Exhibit 4.3 to the Company’s Form 10-K filed with the Commission on March 31, 2022)

EX-4.3 2 f10k2021ex4-3healthlynked.htm DESCRIPTION OF OUR COMMON STOCK EXHIBIT 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 HealthLynked Corp. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: the Company’s common stock, par value $0.0001 per share (t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLy

As filed with the Securities and Exchange Commission on October 13, 2021

As filed with the Securities and Exchange Commission on October 13, 2021 Registration No.

HealthLynked Corp. 2021 Equity Incentive Plan, effective September 9, 2021, as approved by the Company’s stockholders effective October 7, 2021 (incorporated by reference to Exhibit A to the Company’s Information Statement on Schedule 14C filed with the SEC on September 16, 2021)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 INFORMATION STATEMENT PURSUANT TO SECTION 14(C) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED SCHEDULE 14C (RULE 14C-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by R

HealthLynked Announces $2 Million Registered Direct Offering

Exhibit 99.1 HealthLynked Announces $2 Million Registered Direct Offering NAPLES, FL / August 27, 2021 / HealthLynked, Corp. (OTCQB:HLYK) (?HealthLynked? or the ?Company?), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients, and medical data, today announced that it has entered into a securities purchase a

Form of Placement Agent Warrant (Filed as Exhibit 4.2 to the Company’s Form 8-K filed with the Commission on August 30, 2021)

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

HealthLynked Corp. 3,703,704 Shares of Common Stock

Filed pursuant to Rule 424(b)(5) Registration No. 333-255371 PROSPECTUS SUPPLEMENT (To prospectus dated April 26, 2021) HealthLynked Corp. 3,703,704 Shares of Common Stock We are offering 3,703,704 shares of our common stock, par value $0.0001 per share, to a certain institutional investor pursuant to this prospectus supplement and the accompanying prospectus. In a concurrent private placement (th

Engagement Letter with H.C. Wainwright & Co. (Filed as Exhibit 10.2 to the Company’s Form 8-K filed with the Commission on August 30, 2021)

Exhibit 10.2

Form of Investor Warrant (Filed as Exhibit 4.1 to the Company’s Form 8-K filed with the Commission on August 30, 2021)

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

Form of Securities Purchase Agreement (Filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Commission on August 30, 2021)

EX-10.1 5 ea146634ex10-1healthlynked.htm FORM OF SECURITIES PURCHASE AGREEMENT Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of August 26, 2021, between HealthLynked Corp., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and col

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2021 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction (Commission File Number) (IRS Employer o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO

10-Q 1 f10q0321healthlynked.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [

HEALTHLYNKED CORP. 1265 Creekside Parkway, Suite 301 Naples, Florida 34108

HEALTHLYNKED CORP. 1265 Creekside Parkway, Suite 301 Naples, Florida 34108 April 22, 2021 VIA EDGAR United States Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Attn: Ms. Kasey Robinson Re: HealthLynked Corp. Request for Acceleration of Registration Statement on Form S-3 File No. 333-255371 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as

Annual Report - AMENDMENT NO.1 TO FORM 10-K

10-K/A 1 f10k2020a1healthlynkedcorp.htm AMENDMENT NO.1 TO FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1

Amended and Restated Articles of Incorporation (Filed as Exhibit 3.1 to the Company’s Registration Statement on Form S-3 filed with the Commission on April 20, 2021)

EX-3.1 2 ea139566ex3-1healthlynk.htm AMENDED AND RESTATED ARTICLES OF INCORPORATION, AS AMENDED Exhibit 3.1

- REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on April 20, 2021 Registration No.

Description of our Common Stock

EX-4.3 2 f10k2020a1ex4-3healthlyn.htm DESCRIPTION OF OUR COMMON STOCK Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 HealthLynked Corp. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: the Company’s common stock, par value $0.0001 per share (th

Annual Report - ANNUAL REPORT

10-K 1 f10k2020healthlynkedcorp.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commissio

EX-21.1

EX-21.1 3 f10k2020ex21-1healthlynked.htm SUBSIDIARIES EXHIBIT 21.1 Subsidiaries 1. Naples Women’s Center, LLC 2. HLYK Florida, LLC, dba Naples Center for Functional Medicine and dba Cura Health Management 3. ACO Health Partners LLC 4. Bridging the Gap Physical Therapy LLC 5. MEDOFFICEDIRECT L.L.C. dba MedOffice Direct

Form of Director’s Agreement

EX-10.8 2 f10k2020ex10-8healthlynked.htm FORM OF DIRECTOR'S AGREEMENT Exhibit 10.8 DIRECTOR AGREEMENT This DIRECTOR AGREEMENT is made as of (the “Agreement”), by and between HealthLynked Corp., a Nevada corporation (the “Company”), and , an individual (the “Director”). WHEREAS, the Company appointed the Director as of the date hereof, and desires to enter into an agreement with the Director with r

HealthLynked Corporation Announces $2M Equity Investment

Exhibit 99.1 HealthLynked Corporation Announces $2M Equity Investment Naples, FL March 2, 2021 – HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients, and medical data, today announced that a local family office from Naples, Florida has made a $2,000,000 equity investment in

Form of Subscription Agreement, by and between the Company and DanKris1, LLC, dated February 26, 2021 (Filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Commission on March 2, 2021)

EX-10.1 3 ea136871ex10-1healthlynk.htm FORM OF SUBSCRIPTION AGREEMENT, BY AND BETWEEN THE COMPANY AND DANKRIS1, LLC, DATED FEBRUARY 26, 2021 Exhibit 10.1 Execution Subscription Agreement THE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCR

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

8-K 1 ea136871-8khealthylynk.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2021 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jur

Form of Warrant made to DanKris1, LLC, dated February 26, 2021 (Filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Commission on March 2, 2021)

EX-4.1 2 ea136871ex4-1healthlynk.htm FORM OF WARRANT MADE TO DANKRIS1, LLC, DATED FEBRUARY 26, 2021 Exhibit 4.1 Execution NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDE

Warrant made to Iconic Holdings, LLC, dated January 14, 2021 (Filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Commission on January 15, 2021)

EX-4.1 2 ea133475ex4-1health.htm WARRANT MADE TO ICONIC HOLDINGS, LLC, DATED JANUARY 14, 2021 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITI

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

8-K 1 ea133475-8khealthlynked.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2021 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jur

Agreement, by and between the Company and Iconic Holdings, LLC, dated January 14, 2021 (Filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on January 15, 2021)

EX-10.1 3 ea133475ex10-1health.htm AGREEMENT, BY AND BETWEEN THE COMPANY AND ICONIC HOLDINGS, LLC, DATED JANUARY 14, 2021 Exhibit 10.1 AGREEMENT This Agreement (this “Agreement”) is dated as of January 14, 2021, between HealthLynked Corp., a Nevada corporation (the “Company”), and Iconic Holdings, LLC, a Delaware limited liability company (the “Investor”). WHEREAS, subject to the terms and conditi

Financial Statements and Exhibits - AMENDMENT NO.1 TO FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): October 19, 2020 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (I.R.S. Employer Identification

MEDOFFICE DIRECT, LLC Unaudited Condensed Financial Statements For the Nine Months Ended September 30, 2020 and 2019 MEDOFFICE DIRECT, LLC (a Partnership) CONDENSED BALANCE SHEETS

EX-99.2 3 ea132353ex99-2health.htm UNAUDITED CONDENSED FINANCIAL STATEMENTS OF MEDOFFICE DIRECT LLC FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2020 AND 2019 Exhibit 99.2 MEDOFFICE DIRECT, LLC Unaudited Condensed Financial Statements For the Nine Months Ended September 30, 2020 and 2019 MEDOFFICE DIRECT, LLC (a Partnership) CONDENSED BALANCE SHEETS September 30, December 31, 2020 2019 (Unaudited) ASSE

MEDOFFICE DIRECT, LLC AUDITED FINANCIAL STATEMENTS For the Years Ended December 31, 2019 and 2018 INDEPENDENT AUDITOR’S REPORT

Exhibit 99.1 MEDOFFICE DIRECT, LLC AUDITED FINANCIAL STATEMENTS For the Years Ended December 31, 2019 and 2018 INDEPENDENT AUDITOR’S REPORT To those charged with governance of MedOfficeDirect LLC We have audited the accompanying financial statements of MedOfficeDirect LLC (the “Company), a Florida LLC, which comprise of the balance sheets as of December 31, 2019 and 2018, and the related statement

UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

Exhibit 99.3 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Basis of presentation The following unaudited pro forma consolidated balance sheet and statements of income are presented to give effect to the acquisition of MedOfficeDirect, LLC (“MOD”) by HealthLynked Corp (“HealthLynked” or the “Company”). The pro forma information was prepared based on the historical financial statements and r

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT

10-Q 1 f10q0920healthlynked.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ]

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Numb

HealthLynked Corp. Announces the Addition of Dan Hall, VP of Arthrex, to its Board of Directors and Relocation of Corporate Headquarters to the Arthrex Campus

Exhibit 99.1 HealthLynked Corp. Announces the Addition of Dan Hall, VP of Arthrex, to its Board of Directors and Relocation of Corporate Headquarters to the Arthrex Campus Naples, FL November 11, 2020 – HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients and medical data, i

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2020 HealthLynked Corp. (Exact name of registrant as specified in charter) Nevada 000-55768 47-1634127 (State or other jurisdiction of incorporation) (Commission File Numb

HealthLynked Corp. Announces the Addition of Heather Monahan to its Board of Directors Monahan is a best-selling author, keynote speaker, Ted-X speaker, Executive Coach and founder of Boss In Heels

Exhibit 99.1 HealthLynked Corp. Announces the Addition of Heather Monahan to its Board of Directors Monahan is a best-selling author, keynote speaker, Ted-X speaker, Executive Coach and founder of Boss In Heels Naples, FL October 29, 2020 – HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects

2

EX-99.1 3 ea128632ex99-1healthlynked.htm PRESS RELEASE DATED OCTOBER 20, 2020 Exhibit 99.1 HealthLynked Completes Acquisition of MedOfficeDirect, LLC, Adding Discounted Medical Supplies for Patient Members and Healthcare Providers Naples, FL, October 20, 2020 HealthLynked Corp (HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies th

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2020 HealthLynked Corp.

Agreement and Plan of Merger by and among the Company, MOD FL, LLC, a Florida limited liability company and wholly owned subsidiary of Buyer (“Merger Sub”), MedOfficeDirect L.L.C. (the “MOD”) and certain of the members of MOD (Filed as Exhibit 2.1 to the Company’s Form 8-K filed with the Commission on October 21, 2020)

EX-2.1 2 ea128632ex2-1healthlynked.htm AGREEMENT AND PLAN OF MERGER Exhibit 2.1 HEALTHLYNKED CORP. MOD FL, LLC, AND MEDOFFICEDIRECT L.L.C. AGREEMENT AND PLAN OF MERGER Dated as of October 19, 2020 Table of Contents Page ARTICLE I THE MERGER 1 1.1 Effective Time of the Merger 1 1.2 Closing 2 1.3 Effect of the Merger 2 1.4 Organizational Documents 2 1.5 Further Assurances 2 ARTICLE II MERGER CONSIDE

HealthLynked Corp. Receives $3 Million Equity Investment From Its Chairman and CEO

Exhibit 99.1 HealthLynked Corp. Receives $3 Million Equity Investment From Its Chairman and CEO Naples, FL – August 25, 2020 – HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management for its members and a provider of healthcare technologies that connects doctors, patients and medical data, today announced that Dr. Michael Dent, the Chairman and CEO, has made a $3,0

Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

8-K 1 ea126025-8khealthlynked.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): August 20, 2020 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (

Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (Filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Commission on August 26, 2020)

Exhibit 3.1 EXHIBIT A CERTIFICATE OF DESIGNATION OF SERIES B CONVERTIBLE PREFERRED STOCK OF HEALTHLYNKED CORP. HealthLynked Corp. (the “Corporation”), a corporation organized and existing under the laws of Nevada, does hereby certify that, pursuant to authority conferred upon the Board of Directors of the Corporation by the Articles of Incorporation of the Corporation, the Board of Directors of th

Contribution Agreement by and among the Company, The Michael T. Dent, Trustee of the Mary S. Dent Gifting Trust dated January 31, 2006, Michael Thomas Dent, Trustee under the Michael Thomas Dent Declaration of Trust dated March 23, 1998, as amended, and Michael T. Dent dated August 20, 2020 (Filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on August 26, 2020)

Exhibit 10.1 EXHIBIT B CONTRIBUTION AGREEMENT This CONTRIBUTION AGREEMENT (the “Agreement”) is entered into as of August 20, 2020 (“Effective Date”) by and among: The Michael T. Dent, Trustee of the Mary S. Dent Gifting Trust dated January 31, 2006 (the “MTD/MSD Gifting Trust”); Michael Thomas Dent, Trustee under the Michael Thomas Dent Declaration of Trust dated March 23, 1998, as amended (the “M

Quarterly Report - QUARTERLY REPORT

10-Q 1 f10q0620healthlynked.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): May 18, 2020 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (I.R.S. Employer Identification No.

CURA HEALTH MANAGEMENT LLC Audited Consolidated Financial Statements For the Years Ended December 31, 2019 and 2018 INDEPENDENT AUDITOR’S REPORT

Exhibit 99.1 CURA HEALTH MANAGEMENT LLC Audited Consolidated Financial Statements For the Years Ended December 31, 2019 and 2018 INDEPENDENT AUDITOR’S REPORT To those charged with governance of CURA HEALTH MANAGEMENT LLC We have audited the accompanying consolidated financial statements of Cura Health Management LLC (the “Company), a Florida LLC, which comprise of the consolidated balance sheets a

CURA HEALTH MANAGEMENT LLC Unaudited Condensed Consolidated Financial Statements For the Three Months Ended March 31, 2020 and 2019 CURA HEALTH MANAGEMENT LLC (a Partnership) CONDENSED CONSOLIDATED BALANCE SHEETS

Exhibit 99.2 CURA HEALTH MANAGEMENT LLC Unaudited Condensed Consolidated Financial Statements For the Three Months Ended March 31, 2020 and 2019 CURA HEALTH MANAGEMENT LLC (a Partnership) CONDENSED CONSOLIDATED BALANCE SHEETS March 31, December 31, 2020 2019 (Unaudited) ASSETS Current Assets: Cash $ 176,190 $ 551,225 Accounts receivable 52,874 50,346 Prepaid expenses 28,199 63,200 Total Current As

UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

Exhibit 99.3 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Basis of presentation The following unaudited pro forma consolidated balance sheet and statements of income are presented to give effect to the acquisition of Cura Health Management LLC (“CHM”) by HealthLynked Corp (“HealthLynked”). The pro forma information was prepared based on the historical financial statements and related note

21,000,000 Shares HEALTHLYNKED CORP. Common Stock

PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-217309 21,000,000 Shares HEALTHLYNKED CORP. Common Stock This prospectus relates to shares of common stock of HealthLynked Corp. that may be sold by the selling stockholder identified in this prospectus. The shares of common stock offered under this prospectus by the selling stockholder are issuable to Iconic Holdings LLC, or Iconic,

- AMENDMENT NO. 5 TO REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on May 29, 2020 Registration No.

Amendment to Investment Agreement with Iconic Holdings LLC dated May 19, 2020

Exhibit 10.50 AMENDMENT TO INVESTMENT AGREEMENT This Amendment to Investment Agreement, dated as of May 19, 2020 (this “Amendment”), to that certain Investment Agreement, dated July 11, 2016, as amended (the “Agreement”), is entered into by and between HealthLynked Corp., a Nevada corporation, with its principal executive offices at 1726 Medical Blvd Suite 101 Naples, FL 34110 (the “Company”), and

- AMENDMENT NO. 4 TO REGISTRATION STATEMENT

POS AM 1 ea122281-posama4healthlynk.htm AMENDMENT NO. 4 TO REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 22, 2020 Registration No. 333-217309 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 4 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HealthLynked Corp. (Exact Name of Registrant as speci

Amendment to Investment Agreement by and between the Company and Iconic Holdings, LLC dated May 19, 2020 (Filed as Exhibit 10.50 to the Company’s Post-Effective Amendment No. 4 to Form S-1 filed with the Commission on May 22, 2020)

EX-10.50 2 ea122281ex10-50healthlynk.htm AMENDMENT TO INVESTMENT AGREEMENT WITH ICONIC HOLDINGS LLC DATED MAY 19, 2020 Exhibit 10.50 AMENDMENT TO INVESTMENT AGREEMENT This Amendment to Investment Agreement, dated as of May 19, 2020 (this “Amendment”), to that certain Investment Agreement, dated July 11, 2016, as amended (the “Agreement”), is entered into by and between HealthLynked Corp., a Nevada

HealthLynked Closes Acquisition of Cura Health Management, LLC and ACO Health Partners

Exhibit 99.1 HealthLynked Closes Acquisition of Cura Health Management, LLC and ACO Health Partners NAPLES, Florida, May 20, 2020 /PRNewswire/ - HealthLynked Corp (HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connect doctors, patients and medical data, today announced that it closed its acquisition of Cura Health Manage

Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): May 18, 2020 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (I.R.S. Employer Identification No.) 1726 Medical Blv

First Amendment to Agreement and Plan of Merger, dated May 18, 2020, by and among HealthLynked Corp., HLYK Florida, LLC, Cura Health Management LLC, ACO Health Partners, LLC, Bradberry Holdings LLC and FocusOne Holdings, LLC (Filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on May 20, 2020)

Exhibit 10.1 FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (the “Amendment”) is made and entered into as of May 18, 2020 (the “Effective Date”), by and between HealthLynked Corp., a Nevada corporation (the “Parent”), HLYK Florida, LLC, a Florida limited liability company (the “Company”), Cura Health Management LLC, a Florida limited liability

Form of Securities Purchase Agreement with Morningview Financial, LLC dated April 6, 2020 (Filed as Exhibit 10.13 to the Company’s Form 10-Q filed with the Commission on May 15, 2020)

Exhibit 10.13 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 6, 2020, by and between HEALTHLYNKED CORP., a Nevada corporation, with headquarters located at 1726 Medical Blvd., Suite 101, Naples, FL 34110 (the “Company”), and MORNINGVIEW FINANCIAL, LLC, a Wyoming limited liability company, with its address at 401 Park Ave. South, 10th Floor, Ne

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

Form of Securities Purchase Agreement with Platinum Point Capital LLC dated April 2, 2020 (Filed as Exhibit 10.11 to the Company’s Form 10-Q filed with the Commission on May 15, 2020)

EX-10.11 2 f10q0320ex10-11healthlynked.htm FORM OF SECURITIES PURCHASE AGREEMENT WITH PLATINUM POINT CAPITAL LLC DATED APRIL 2, 2020 Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 2, 2020, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd., Suite 101, Naples, Florida 34110 (the “Compan

Form of Convertible Promissory Note with Platinum Point Capital LLC dated April 2, 2020 (Filed as Exhibit 10.12 to the Company’s Form 10-Q filed with the Commission on May 15, 2020)

Exhibit 10.12 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Convertible Promissory Note with Morningview Financial, LLC dated April 6, 2020 (Filed as Exhibit 10.14 to the Company’s Form 10-Q filed with the Commission on May 15, 2020)

EX-10.14 5 f10q0320ex10-14healthlynked.htm FORM OF CONVERTIBLE PROMISSORY NOTE WITH MORNINGVIEW FINANCIAL, LLC DATED APRIL 6, 2020 Exhibit 10.14 NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECU

Form of Convertible Promissory Note with Power Up Lending Group Ltd. dated April 6, 2020 (Filed as Exhibit 10.16 to the Company’s Form 10-Q filed with the Commission on May 15, 2020)

Exhibit 10.16 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Securities Purchase Agreement with Power Up Lending Group Ltd. dated April 30, 2020 (Filed as Exhibit 10.17 to the Company’s Form 10-Q filed with the Commission on May 15, 2020)

EX-10.17 8 f10q0320ex10-17healthlynked.htm FORM OF SECURITIES PURCHASE AGREEMENT WITH POWER UP LENDING GROUP LTD. DATED APRIL 30, 2020 Exhibit 10.17 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 30, 2020, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd Suite 101, Naples, Florida 34110 (the “Compa

Form of Convertible Promissory Note with Power Up Lending Group Ltd. dated April 30, 2020 (Filed as Exhibit 10.18 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on May 15, 2020)

Exhibit 10.18 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Securities Purchase Agreement with Power Up Lending Group Ltd. dated April 6, 2020 (Filed as Exhibit 10.15 to the Company’s Form 10-Q filed with the Commission on May 15, 2020)

Exhibit 10.15 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 6, 2020, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd Suite 101, Naples, Florida 34110 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): May 8, 2020 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (I.R.S. Employer Identification No.) 1726 Medical Blvd

2

Exhibit 99.1 Paycheck Protection Program Promissory Note and Agreement Wells Fargo SBA Lending Borrower Names: Healthlynked Corp Important Notice: This Instrument Contains A Confession Of Judgment Provision Which Constitutes A Waiver Of Important Rights You May Have As A Debtor And Allows The Creditor To Obtain A Judgment Against You Without Any Further Notice. Venue Will Be In The City Of Richmon

2

Exhibit 99.3 Paycheck Protection Program Promissory Note and Agreement Wells Fargo SBA Lending Borrower Names: Hlyk Florida Llc Doing Business As Naple Important Notice: This Instrument Contains A Confession Of Judgment Provision Which Constitutes A Waiver Of Important Rights You May Have As A Debtor And Allows The Creditor To Obtain A Judgment Against You Without Any Further Notice. Venue Will Be

2

Exhibit 99.2 Paycheck Protection Program Promissory Note and Agreement Wells Fargo SBA Lending Borrower Names: Naples Women Center Important Notice: This Instrument Contains A Confession Of Judgment Provision Which Constitutes A Waiver Of Important Rights You May Have As A Debtor And Allows The Creditor To Obtain A Judgment Against You Without Any Further Notice. Venue Will Be In The City Of Richm

HealthLynked Corp. Secures $585,000 in Paycheck Protection Program (PPP) Loans

Exhibit 99.4 HealthLynked Corp. Secures $585,000 in Paycheck Protection Program (PPP) Loans Naples, FL May 12, 2020 – HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients and medical data, today announced that it has received funding under the Paycheck Protection Program (PP

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): March 31, 2020 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (I.R.S. Employer Identification No.) 1726 Medical B

HealthLynked Reports Third Consecutive Quarter of Record Year-Over-Year Revenue Growth of 131%

EX-99.1 2 ea120322-8kex991healthlynk.htm PRESS RELEASE, DATED MARCH 31, 2020 Exhibit 99.1 HealthLynked Reports Third Consecutive Quarter of Record Year-Over-Year Revenue Growth of 131% Naples, FL March 31, 2020 – HealthLynked Corp. (OTCQB: HLYK), a provider of healthcare-related technology that connects doctors, patients and medical data, late yesterday reported its financial results for the quart

Form of Securities Purchase Agreement with Jefferson Street Capital LLC dated December 2, 2019 (Filed as Exhibit 10.36 to the Company’s Annual Report on Form 10-K filed with the Commission on March 30, 2020)

Exhibit 10.36 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 2, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd, Suite 101, Naples, Florida 34110 (the “Company”), and Jefferson Street Capital LLC, a New Jersey limited liability company with its address at 720 Monroe Street, Suite C401B, H

Form of Convertible Promissory Note with Jefferson Street Capital LLC dated December 2, 2019 (Filed as Exhibit 10.37 to the Company’s Annual Report on Form 10-K filed with the Commission on March 30, 2020)

Exhibit 10.37 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Securities Purchase Agreement with Power Up Lending Group Ltd. dated January 22, 2020 (Filed as Exhibit 10.42 to the Company’s Annual Report on Form 10-K filed with the Commission on March 30, 2020)

Exhibit 10.42 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 16, 2020, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd Suite 101, Naples, Florida 34110 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 110

HLYK / HealthLynked Corp. 10-K - Annual Report - ANNUAL REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-55768 HealthLynked Corp. (Exact

Form of Convertible Promissory Note with BHP Capital NY Inc. dated January 13, 2020 (Filed as Exhibit 10.39 to the Company’s Annual Report on Form 10-K filed with the Commission on March 30, 2020)

Exhibit 10.39 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Securities Purchase Agreement with BHP Capital NY Inc. dated January 13, 2020 (Filed as Exhibit 10.38 to the Company’s Annual Report on Form 10-K filed with the Commission on March 30, 2020)

Exhibit 10.38 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 13, 2020, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd, Suite 101, Naples, Florida 34110 (the “Company”), and BHP Capital NY, Inc. (the “Buyer”). WHEREAS A. The Company and the Buyer are executing and delivering this Agreement in re

Form of Convertible Promissory Note with Power Up Lending Group Ltd. dated January 22, 2020 (Filed as Exhibit 10.43 to the Company’s Annual Report on Form 10-K filed with the Commission on March 30, 2020)

Exhibit 10.43 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

List of Subsidiaries (Filed as Exhibit 21.1 to the Company’s Form 10-K filed with the Commission on March 30, 2020)

Exhibit 21.1 Subsidiaries Naples Women’s Center, LLC HLYK Florida, LLC Bridging the Gap Physical Therapy LLC

Form of Convertible Promissory Note with BHP Capital NY Inc. dated March 13, 2020 (Filed as Exhibit 10.47 to the Company’s Annual Report on Form 10-K filed with the Commission on March 30, 2020)

Exhibit 10.47 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Securities Purchase Agreement with BHP Capital NY Inc. dated March 13, 2020 (Filed as Exhibit 10.46 to the Company’s Annual Report on Form 10-K filed with the Commission on March 30, 2020)

Exhibit 10.46 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 10, 2020, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd, Suite 101, Naples, Florida 34110 (the “Company”), and BHP Capital NY, Inc., a New York corporation (the “Buyer”). WHEREAS A. The Company and the Buyer are executing and deliverin

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): February 5, 2020 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (I.R.S. Employer Identification No.) 1726 Medical

Agreement and Plan of Merger, dated February 5, 2020, by and among HealthLynked Corp., HLYK Florida, LLC, Cura Health Management LLC, ACO Health Partners, LLC, Bradberry Holdings LLC and FocusOne Holdings, LLC (Filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on February 11, 2020)

Exhibit 10.1 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (the “Agreement”) is made as of February 5, 2020 (the “Effective Date”), by and between HealthLynked Corp., a Nevada corporation (the “Parent”), HLYK Florida, LLC, a Florida limited liability company (the “Company”), Cura Health Management LLC, a Florida limited liability company (the “Target”), ACO Health Partners, LLC, a

2

EX-99.1 3 f8k020520ex99-1health.htm PRESS RELEASE, DATED FEBRUARY 11, 2020 Exhibit 99.1 HealthLynked Signs Definitive Agreement to Acquire Cura Health Management, LLC, and ACO Health Partners, LLC Adding Significant Revenue and Profitability from its Newly Formed Accountable Care Organization Division Naples, FL, Feb 11, 2020 HealthLynked Corp (HLYK), a nationwide healthcare network focused on car

Shareholder Letter, dated January 9, 2020 (Filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the Commission on January 13, 2020)

Exhibit 99.1

Presentation Materials (Filed as Exhibit 99.2 to the Company’s Current Report on Form 8-K filed with the Commission on January 13, 2020)

Exhibit 99.2

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): January 9, 2020 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (I.R.S. Employer Identification No.) 1726 Medical

1

Exhibit 99.1 HealthLynked Corp. Announces the Addition of Robert P. Mino to Its Board of Directors NAPLES, Florida, Nov. 26, 2019 /PRNewswire/ - InvestorsHub NewsWire - HealthLynked Corp. (OTCQB: HLYK), a nationwide healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients and medical data, is pleased to announce the addi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): November 26, 2019 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (I.R.S. Employer Identification No.) 1726 Medica

Form of Securities Purchase Agreement with Power Up Lending Group Ltd. dated November 4, 2019 (Filed as Exhibit 10.17 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on November 14, 2019)

Exhibit 10.17 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 4, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd Suite 101, Naples, Florida 34110 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 110

Form of Convertible Promissory Note with Iconic Holdings LLC dated October 1, 2019 (Filed as Exhibit 10.10 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on November 14, 2019)

Exhibit 10.10 Note: October 1, 2019 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STAT

Form of Convertible Promissory Note with BHP Capital NY Inc. dated October 30, 2019 (Filed as Exhibit 10.14 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on November 14, 2019)

Exhibit 10.14 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Convertible Promissory Note with BHP Capital NY Inc. dated August 26, 2019

Exhibit 10.9 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Convertible Promissory Note with Power Up Lending Group Ltd. dated October 1, 2019

Exhibit 10.12 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Securities Purchase Agreement with BHP Capital NY Inc. dated October 30, 2019 (Filed as Exhibit 10.13 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on November 14, 2019)

Exhibit 10.13 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 30, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd, Suite 101, Naples, Florida 34110 (the “Company”), and BHP Capital, Inc. (the “Buyer”). WHEREAS A. The Company and the Buyer are executing and delivering this Agreement in relia

Form of Convertible Promissory Note with Power Up Lending Group Ltd. dated November 4, 2019 (Filed as Exhibit 10.18 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on November 14, 2019)

Exhibit 10.18 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Securities Purchase Agreement with BHP Capital NY Inc. dated August 26, 2019

Exhibit 10.8 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 26, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd, Suite 101, Naples, Florida 34110 (the “Company”), and BHP Capital, Inc. (the “Buyer”). WHEREAS A. The Company and the Buyer are executing and delivering this Agreement in relianc

Form of Convertible Promissory Note with Morningview Financial LLC dated October 30, 2019 (Filed as Exhibit 10.16 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on November 14, 2019)

Exhibit 10.16 NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

HLYK / HealthLynked Corp. 10-Q - Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLy

Form of Securities Purchase Agreement with Morningview Financial LLC dated October 30, 2019 (Filed as Exhibit 10.15 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on November 14, 2019)

Exhibit 10.15 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 30, 2019, by and between HEALTHLYNKED CORP., a Nevada corporation, with headquarters located at 1726 Medical Blvd., Suite 101, Naples, FL 34110 (the “Company”), and MORNINGVIEW FINANCIAL, LLC, a Wyoming limited liability company, with its address at 401 Park Ave. South, 10th Floor,

Form of Securities Purchase Agreement with Power Up Lending Group Ltd. dated October 1, 2019 (Filed as Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on November 14, 2019)

Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 1, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd Suite 101, Naples, Florida 34110 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 1102

Form of Convertible Promissory Note with Power Up Lending Group Ltd. dated July 16, 2019 (Filed as Exhibit 10.32 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on August 14, 2019)

Exhibit 10.32 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Convertible Promissory Note with Morningview Financial LLC dated June 3, 2019

Exhibit 10.27 NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

Form of Securities Purchase Agreement with Morningview Financial LLC dated June 3, 2019

EX-10.26 2 f10q0619ex10-26healthlynked.htm FORM OF SECURITIES PURCHASE AGREEMENT WITH MORNINGVIEW FINANCIAL LLC DATED JUNE 3, 2019 Exhibit 10.26 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 3, 2019, by and between HEALTHLYNKED CORP., a Nevada corporation, with headquarters located at 1726 Medical Blvd., Suite 101, Naples, FL 34110 (the “Compa

Form of Convertible Promissory Note with BHP Capital NY Inc. dated July 11, 2019 (Filed as Exhibit 10.29 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on August 14, 2019)

Exhibit 10.29 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Securities Purchase Agreement with GS Capital Partners LLC dated July 18, 2019 (Filed as Exhibit 10.33 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on August 14, 2019)

Exhibit 10.33 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 18, 2019 by and between HealthLynked Corp., a Nevada corporation, with headquarters located at 1726 Medical Blvd., Suite 101, Naples, FL 34110 (the “Company”) and GS CAPITAL PARTNERS, LLC, with its address at 30 Broad Street, Suite 1201, New York, NY 10004, (the “Buyer”). WHEREAS: A.

Form of Convertible Promissory Note with GS Capital Partners LLC dated July 18, 2019 (Filed as Exhibit 10.34 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on August 14, 2019)

Exhibit 10.34 THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”) US $230,

Form of Convertible Promissory Note with Jefferson Street Capital LLC dated July 11, 2019 (Filed as Exhibit 10.30 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on August 14, 2019)

Exhibit 10.30 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

HLYK / HealthLynked Corp. 10-Q - Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

Form of Securities Purchase Agreement with BHP Capital NY Inc. and Jefferson Street Capital LLC dated July 11, 2019 (Filed as Exhibit 10.28 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on August 14, 2019)

Exhibit 10.28 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 11, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd, Suite 101, Naples, Florida 34110 (the “Company”), and each of the buyers as set forth on Schedule I hereto (the “Buyers” and each a “Buyer”). WHEREAS: A. The Company and the Buyer

Form of Securities Purchase Agreement with Power Up Lending Group Ltd. dated July 16, 2019 (Filed as Exhibit 10.31 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on August 14, 2019)

Exhibit 10.31 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 16, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd Suite 101, Naples, Florida 34110 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021

HLYK / HealthLynked Corp. POS AM - - AMENDMENT NO. 3 TO REGISTRATION STATEMENT

POS AM 1 posam2019a3healthlynkedcorp.htm AMENDMENT NO. 3 TO REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on June 20, 2019 Registration No. 333-217309 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 3 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HealthLynked Corp. (Exact Name of Registrant as spe

Post Effective Amendment No. 2

As filed with the Securities and Exchange Commission on June 17, 2019 Registration No.

Form of Securities Purchase Agreement with Power Up Lending Group Ltd. dated April 3, 2019 (Filed as Exhibit 10.18 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.18 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 3, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd Suite 101, Naples, Florida 34110 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021

Form of Securities Purchase Agreement with BHP Capital NY Inc. dated January 14, 2019 (Filed as Exhibit 10.11 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 14, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd, Suite 101, Naples, Florida 34110 (the “Company”), and BHP CAPITAL NY INC., a New York corporation, with its address at 245 East 40th Street, Suite 28B New York, New York 10016

Form of Securities Purchase Agreement with Power Up Lending Group Ltd. dated January 24, 2019 (Filed as Exhibit 10.15 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.15 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 24, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd, Suite 101, Naples, Florida 34110 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11

Form of Convertible Promissory Note with BHP Capital NY Inc. dated January 14, 2019 (Filed as Exhibit 10.12 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

EX-10.12 3 f10q0319ex10-12health.htm FORM OF CONVERTIBLE PROMISSORY NOTE WITH BHP CAPITAL NY INC. DATED JANUARY 14, 2019 Exhibit 10.12 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY

HLYK / HealthLynked Corp. 10-Q Quarterly Report QURATERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10–Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number: 000-55768 HealthLynked

Form of Securities Purchase Agreement with Power Up Lending Group Ltd. dated May 7, 2019 (Filed as Exhibit 10.24 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.24 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 7, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd Suite 101, Naples, Florida 34110 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (t

Form of Convertible Promissory Note with Power Up Lending Group Ltd. dated May 7, 2019 (Filed as Exhibit 10.25 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.25 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Convertible Promissory Note with Jefferson Street Capital LLC dated April 11, 2019 (Filed as Exhibit 10.22 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.22 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Convertible Promissory Note with BHP Capital NY Inc. dated April 11, 2019 (Filed as Exhibit 10.21 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.21 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Convertible Promissory Note with Power Up Lending Group Ltd. dated January 24, 2019 (Filed as Exhibit 10.16 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.16 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Securities Purchase Agreement with BHP Capital NY Inc. and Jefferson Street Capital LLC dated April 11, 2019 (Filed as Exhibit 10.20 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.20 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 11, 2019, by and between HealthLynked Corp., a Nevada corporation, with its address at 1726 Medical Blvd, Suite 101, Naples, Florida 34110 (the “Company”), and each of the buyers as set forth on Schedule I hereto (the “Buyers” and each a “Buyer”). WHEREAS: A. The Company and the Buye

Form of Convertible Promissory Note with Power Up Lending Group Ltd. dated April 3, 2019 (Filed as Exhibit 10.19 to the Company’s Form 10-Q filed with the Commission on May 15, 2019)

Exhibit 10.19 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE

Form of Convertible Promissory Note with Iconic Holdings LLC dated April 15, 2019 (Filed as Exhibit 10.23 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on May 15, 2019)

EX-10.23 11 f10q0319ex10-23health.htm FORM OF CONVERTIBLE PROMISSORY NOTE WITH ICONIC HOLDINGS LLC DATED APRIL 15, 2019 Exhibit 10.23 Note: April 15, 2019 NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 19

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 f8k043019healthlynkedcorp.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): April 30, 2019 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation)

HealthLynked Corp. Announces the Addition of Bob Gasparini to its Board of Directors

Exhibit 99.1 HealthLynked Corp. Announces the Addition of Bob Gasparini to its Board of Directors NAPLES, Fla., April 30, 2019 (GLOBE NEWSWIRE) - HealthLynked Corp. (HLYK) today announced the addition of Bob Gasparini to its Board of Directors. Mr. Gasparini was a key executive at NeoGenomics Laboratories serving in many capacities with the company including President and Chief Scientific Officer

Hughes center for functional medicine Pa Audited Financial Statements For the Years Ended December 31, 2018 and 2017 HUGHES CENTER FOR FUNCTIONAL MEDICINE PA (an S Corporation)

Exhibit 99.2 Hughes center for functional medicine Pa Audited Financial Statements For the Years Ended December 31, 2018 and 2017 HUGHES CENTER FOR FUNCTIONAL MEDICINE PA (an S Corporation) TABLE OF CONTENTS Independent Auditor’s Report 1 Financial Statements Balance Sheets as of December 31, 2018 and 2017 2 Statements of Income and Retained Earnings as of December 31, 2018 and 2017 3 Statements o

UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

Exhibit 99.3 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Basis of presentation The following unaudited pro forma combined balance sheet and statements of income are presented to give effect to the acquisition of Hughes Center for Functional Medicine, P.A. (“HCFM”) by HealthLynked Corp (“HealthLynked”). The pro forma information was prepared based on the historical financial statements an

Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): April 12, 2019 HealthLynked Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 47-1634127 (State of Incorporation) (I.R.S. Employer Identification No.) 1726 Medical B

First Amendment to Agreement and Plan of Merger, dated April 12, 2019, by and among HealthLynked Corp., HLYK Florida, LLC, Hughes Center for Functional Medicine, P.A., and Pamela A. Hughes, D.O. (Filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on April 18, 2019)

Exhibit 10.1 FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (the “Amendment”) is made and entered into as of April 12, 2019 (the “Effective Date”), by and between HealthLynked Corp., a Nevada corporation (the “Parent”), HLYK Florida, LLC, a Florida limited liability company (the “Company”), Hughes Center for Functional Medicine, P.A. (the “Targ